Furthermore, silencing of FANCI resulted in significant downregulation of several FA complex members both at mRNA and protein levels, indicating the potential regulatory function of FANCI on the FA pathway in prostate cancer cells. This evidence concerns the gene FANCI and prostate carcinoma.